Predictors of hepatorenal syndrome in alcoholic liver cirrhosis

被引:11
|
作者
Janicko, Martin [1 ]
Veseliny, Eduard [1 ]
Senajova, Gabriela [1 ]
Jarcuska, Peter [1 ]
机构
[1] Safarik Univ, Univ Hosp, Dept Internal Med 1, Kosice, Slovakia
来源
BIOMEDICAL PAPERS-OLOMOUC | 2015年 / 159卷 / 04期
关键词
alcohol; liver cirrhosis; hepatorenal syndrome; predictors; SPONTANEOUS BACTERIAL PERITONITIS; RENAL IMPAIRMENT; PROGNOSIS; ASCITES; HYPONATREMIA; MORTALITY; SURVIVAL; IMPROVES; DISEASE;
D O I
10.5507/bp.2015.010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background. Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored. Aim. To assess the risk factors for hepatorenal syndrome in alcoholic liver cirrhosis. Patients and Methods. Consecutive patients with alcoholic liver disease were followed for two months, development of renal failure, classified either as HRS or renal failure not fulfilling criteria of HRS, was the main outcome. Results. Of 171 patients, 14 (8.2%) developed HRS and 13 (7.6%), renal failure not fulfilling the HRS criteria. A significant difference was found between patients with and without HRS in serum sodium (131.1 +/- 3.8 vs. 135.7 +/- 5.2; P = 0.003), creatinine, (94.1 +/- 26.8 vs. 80.3 +/- 20.2; P < 0.001), albumin (23.5 +/- 4.9 vs. 29.9 +/- 5.8; P < 0.001), INR (1.76 +/- 0.45 vs. 1.44 +/- 0.41; P < 0.001), bilirubin (252.3 +/- 179.4 vs. 91.2 +/- 101.0; P < 0.001), MELD (23 +/- 6 vs 15 +/- 5; P < 0.001) and MELD-Na score (27 +/- 5 vs. 18 +/- 6; P < 0.001). Multivariate analysis adjusted for sex and age showed that sodium together with creatinine are the strongest HRS predictors, followed by bilirubin with respective odds' ratios (95% CI) of 1.041 (1.012-1.072) for creatinine, 0.870 (0.766-0.988) for serum sodium and 1.005 (1.001-1.010) for serum bilirubin. Conclusion. Serum levels of sodium, creatinine and bilirubin are important predictors of the hepatorenal syndrome.
引用
收藏
页码:661 / 665
页数:5
相关论文
共 50 条
  • [1] Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
    Deorukhkar, Durga
    Sonawale, Archana
    Goyal, Aman
    Sonawale, Kshitij
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [2] VASOPRESSOR THERAPY OF HEPATORENAL SYNDROME AGAINST THE BACKGROUND OF ALCOHOLIC LIVER CIRRHOSIS
    Slyvka, N. O.
    Lukashiv, T. O.
    Rusnak, I. T.
    Sydorchuk, A. S.
    Al Salama, M. V. O.
    Rovinskyi, O. O.
    Akentiev, S. O.
    WORLD OF MEDICINE AND BIOLOGY, 2021, 77 (03): : 158 - 162
  • [3] Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis
    Nickovic, Vanja
    Nikolic, Jelenka
    Djindjic, Natasa
    Ilic, Milena
    Nickovic, Jovan
    Mladenovic, Dragan
    Krstic, Nebojsa
    VOJNOSANITETSKI PREGLED, 2012, 69 (08) : 686 - 691
  • [4] Treatment of hepatorenal syndrome in liver cirrhosis
    Biecker, E
    Brensing, KA
    Perz, J
    Woitas, R
    Sauerbruch, T
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (36) : 1039 - 1042
  • [5] PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS (ALC), HEPATORENAL SYNDROME (HRS) AND HISTOLOGICAL EVIDENCE OF ACUTE ALCOHOLIC HEPATITIS (AAH) IN EXPLANTED LIVER
    Borro, P.
    Sumberaz, A.
    Andorno, E.
    Ferro, C.
    Scafato, E.
    Testino, G.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S80 - S80
  • [6] Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis
    Schmidt, L. E.
    Ring-Larsen, H.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (35) : 4637 - 4647
  • [7] HEPATORENAL INSUFFICIENCY IN ALIMENTARY TOXINFECTIONS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER
    BRODOV, LE
    KARETKINA, GN
    YUSHCHUK, ND
    MALEEV, VV
    KLINICHESKAYA MEDITSINA, 1985, 63 (07): : 82 - 85
  • [8] Severe alcoholic hepatitis versus advanced cirrhosis: Prevalence of sepsis hepatorenal syndrome, hyperfibrinolysis and predictors of mortality
    Verma, S
    Ajudia, K
    Mendler, M
    Redeker, A
    GASTROENTEROLOGY, 2004, 126 (04) : A692 - A693
  • [9] Management of hepatorenal syndrome in liver cirrhosis: a recent update
    Bera, Chinmay
    Wong, Florence
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [10] Alcoholic cirrhosis-associated hepatorenal syndrome treated with vasoactive agents
    Eric Esrailian
    Bruce A Runyon
    Nature Clinical Practice Nephrology, 2006, 2 : 169 - 172